Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models.
Tang YC, Ou JJ, Hsu SC, Huang CH, Lin LM, Chang HH, Wang YH, Huang ZT, Sun M, Liu KJ, Hung YM, Lai CY, Shih C, Chen CT, Chang JY, Hsieh HP, Jiaang WT, Kuo CC.
Tang YC, et al. Among authors: hsu sc.
Pharmacol Res. 2024 Dec 20;211:107556. doi: 10.1016/j.phrs.2024.107556. Online ahead of print.
Pharmacol Res. 2024.
PMID: 39709137
Free article.